Remgro’s stake in spotlight at competition hearing
Concerned parties question a possible conflict of interest and information cross-sharing
15 March 2023 - 21:23
Remgro’s shareholding in Discovery and Momentum Metropolitan Holdings (MMH) came into sharp focus at the public hearings held by the Competition Tribunal over the multibillion-rand takeover of Mediclinic by a consortium led by Remgro.
Remgro, Johann Rupert’s investment vehicle, already owns 44.56% of Mediclinic. The company, in partnership with Mediterranean Shipping Company SA (MSC), last year made an offer of £3.7bn to acquire the rest of Mediclinic and delist it from the JSE. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.